NGM Bio Announces Oral Plenary Presentation of 24-Week Phase 2 Study (Cohort 4) of Aldafermin in Patients with NASH at The Digital International Liver Congress™ (ILC) 2020

Suma Ramadas, PhD
Medical Affairs

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach